Thrombosis Events Tied To Gene Mutation In Stent Patients On Clopidogrel
This article was originally published in The Pink Sheet Daily
Executive Summary
Three independent research teams say they have document a strong link between a metabolizing gene and the prognosis for stented heart disease patients taking the standard anti-platelet medicine Plavix.
You may also be interested in...
Lilly, Daiichi Explore Pharmacogenomic Marker For Prasugrel
A May 4 Circulation article describing prasugrel's efficacy in patients who carry a genetic marker indicative of non-response to Plavix may be the opening volley in one of the first big marketing battles of the personalized medicine era
Lilly, Daiichi Explore Pharmacogenomic Marker For Prasugrel
A May 4 Circulation article describing prasugrel's efficacy in patients who carry a genetic marker indicative of non-response to Plavix may be the opening volley in one of the first big marketing battles of the personalized medicine era
Daiichi Sankyo, Lilly Explore Pharmacogenomic Marker For Prasugrel
A May 4 Circulation article describing prasugrel's efficacy in patients who carry a genetic marker indicative of non-response to Plavix may be the opening volley in one of the first big marketing battles of the personalized medicine era